Physician profile
John D Mccarthy
NPI 1679650923
$637.93
in general payments reported to CMS, 2019-2025
10 companies · $56.66 in 2025
The $56.66 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $11.40 · 2021: $59.97 · 2022: $111 · 2024: $142 · 2025: $56.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Products, Lp | $216.48 | 2019-2022 | |
| Shionogi INC | $154.08 | 2022-2024 | Fetroja |
| Insmed, INC. | $74.99 | 2019 | |
| Viiv Healthcare Company | $36.87 | 2019-2020 | |
| Astellas Pharma US INC | $28.99 | 2019 | |
| Boston Scientific Corporation | $28.94 | 2025 | Wavewriter Alpha Prime 16 |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Paratek Pharmaceuticals, INC. | $27.72 | 2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $27.70 | 2019 | |
| Gilead Sciences, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.